BACKGROUND: Cytopathology is a noninvasive and cost-effective method for detecting cancer cells in pleural effusions (PEs), although in many cases, the diagnostic performance is hindered by the paucity of significant cells or the lack of clear morphological criteria. This study presents the results of an omics approach to improving the diagnostic performance of PE cytology. METHODS: Metabolic profiling with proton nuclear magnetic resonance ( 1 H-NMR) was performed for 
INTRODUCTION
A pleural effusion (PE), defined as the presence of an abnormal fluid quantity within the pleural cavity, is one of the most common pathological signs revealed by a physical examination and chest X-ray analysis. When it is symptomatic, a thoracentesis is required to give immediate relief to the patient and to collect the fluid for diagnosis and research. The direct recognition and identification of atypical cells permit the recognition of a malignancy and an understanding of its origin (a malignant pleural effusion [mPE] , which is cancer-related, or a benign pleural effusion [bPE] , which is not cancer-related).
The first step in a PE analysis to differentiate a transudative PE from an exudative PE relies on Light's criteria. According to Light's criteria, at least 1 of the following is sufficient to classify an effusion as an exudate: a PE/ serum protein ratio greater than 0.5, a PE/serum lactate dehydrogenase ratio greater than 0.5, and a PE lactate dehydrogenase concentration greater than two-thirds of the upper limit of the normal serum level. 1 However, there are serious limits: more than 25% of patients with transudative PEs are wrongly identified as having exudative PEs. 2 Additional testing, including routine analysis, biochemistry, and cytology, is necessary. In particular, cytology, because of its rapidity and low costs, is the gold standard for confirming the nature of an mPE; it has high specificity but low sensitivity (approximately 50%), and this is mainly related to the operator's expertise. 3 Among the additional methods for increasing PE sensitivity and accuracy are various tumor markers such as carcinoembryonic antigen (CEA), cancer antigen 125 (CA 125), cytokeratin 19 fragments (CYFRA 21-1), carbohydrate antigen , and carbohydrate antigen . 4 [4] [5] [6] [7] Other recent studies have investigated the feasibility of molecular tests providing a good performance in terms of nucleic acid isolation, 8 sensitivity and accuracy in the differential diagnosis between malignant pleural mesothelioma and reactive pleuritis, 9 and RNA extraction from exosomes.
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Metabonomics by high-resolution proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy has been recently demonstrated to be helpful and reliable. Unlike metabolomics, which deals with normal metabolism, metabonomics investigates the entire metabolic profile of tissues or biofluids with the aim of enlightening the perturbation induced by diseases on the normal endogenous metabolism. The latent information embedded in the vast mass of spectroscopic data is extracted via coupling with several multivariate statistics (mainly principal component analysis [PCA] , partial least squares fitting, partial least squares discriminant analysis [PLS-DA], orthogonal projection of latent structures, and discriminant function analysis [11] [12] [13] , and this reveals the main metabolites that could be entitled to recognition as potential biomarkers for metabolic perturbative diseases. The vast majority of 1 H-NMR spectroscopy clinical research is usually performed on urine and serum specimens 14 because such samples can be withdrawn by relatively noninvasive means and perhaps because these fluids have the greatest potential to provide diagnostic information on the general health of an organism. 15, 16 There are very few publications on 1 H-NMR PE metabonomics, although some recent work has confirmed its importance. 17, 18 Compared with urine and plasma, PEs have the advantage of being much less influenced by the diet and lifestyle of individuals, which are 2 two of the major drawbacks when the variability of a patient's metabolic profile is considered. Moreover, the pleura is a closed membrane that acts as a selective semipermeable filter. Because of its high selective capacity for filtrating and concentrating small plasma metabolites, PEs are ideal fluids for investigating the presence of small molecules and hopefully new cancer biomarkers, which are less masked from the large proteins such as albumin present at high concentrations in the blood. 4 This and the high sensitivity of 1 H-NMR spectroscopy make PEs particularly suitable for research into new tumor markers by nuclear magnetic resonance (NMR)-based metabonomics. The contribution of 1 H-NMR spectroscopy to a reliable classification of PEs as transudates or exudates and to differentiation between pleural effusions (mPEs) and bPEs was initially investigated. The validation of the obtained results was performed by comparison with traditional cytology analysis and Light's criteria set. Multivariate statistics (PCA and partial least squares fitting) were then applied to the metabolic profile spectroscopic data set with the aim of finding a set of metabolites that could drive the discrimination and be potentially interesting as cancer biomarkers.
MATERIALS AND METHODS

Ethics
This study was approved by the institutional ethical review board of Padua University, which waived the need for consent for using archival material (approval no. 50449), and we followed all the ethical regulations of the institute regarding research conducted on archival human tissues.
Human PE Harvesting, Light's Criteria, and Cytology Ninety-two PEs were collected between 2011 and 2012 at the Surgical Pathology and Cytopathology Unit at Padua University; 44 came from cancer patients, and 48 were noncancer controls with cardiac failure (clinical and pathological data are reported in Table 1 ).
All the PE samples were centrifuged within 1 hour of their withdrawal at 2000g for 10 minutes at room temperature. The precipitate was used to prepare 2 slides for cytology, whereas 4 mL of each supernatant was divided into 2 parts (to produce 2 identical samples of the same PE Original Article for repeated analysis), transferred into 2-mL sterile tubes, and centrifuged at 2000g for 20 minutes at 48C. The PE supernatants were then stored at -808C until use.
According to Light's criteria, each sample was classified as a transudate or an exudate. Two cytopathologists (A.F. and R.C.) examined all cases independently and defined the 2 cohorts of mPEs and bPEs. In the mPE cohort, we included only cases with histological confirmation of malignancy (Fig. 1A,B ).
Chemicals and Reagents
All chemicals were purchased from Sigma-Aldrich: anhydrous sodium hydrogen phosphate (Na 2 HPO 4 ) and anhydrous monosodium phosphate (NaH 2 PO 4 ; 99%), sodium azide (NaN 3 
PE Sample Treatment for the NMR Investigation
We followed a rigorous protocol for NMR sample preparation. To minimize the variability in pH that could potentially characterize PEs from different individuals, each PE sample was defrosted from -808C immediately before the NMR analysis and was rapidly diluted in a phosphate buffer (80:20 vol/vol) to a final pH of 7.30 6 0.02. The solution was then quickly centrifuged at 12,000g for 5 minutes at 48C. Finally, 600 lL of the buffered sample was transferred into a 5-mm NMR tube, which was immediately inserted into the spectrometer for the metabonomic assay. C probe with a 5-mm outer diameter was used; it was equipped with a Z gradient facility. For each sample, 2 different 1-dimensional (1D) NMR spectra were acquired: a 1D Carr-Purcell-Meiboom-Gill (CPMG) spin-echo sequence (cpmgpr in the Bruker library) and a 1D diffusion-edited sequence (ledbpgppr2s1d in the Bruker library). The 1D CPMG sequence was used to attenuate the broad signal from macromolecules (eg, proteins) that might be present in a sample; this permitted a better evaluation of low-molecular-weight species (metabolites). This sequence was preferred to deproteinization procedures 17 to preserve minimum perturbation of the biological fluid. Water peak suppression was obtained by presaturation (CPMG presaturation) with a standard zgpr pulse sequence. The 1D diffusion-edited sequence was used instead to better visualize the signal from higher molecular weight species (eg, lipids and lipoproteins). The spectra were recorded with 64 or 128 scans, 64,000 data points, a spectral width of 30 ppm (8971 Hz), 4 dummy scans, and a relaxation delay of 4 s. All 1D spectra were processed with line broadening of 0.3 Hz before the Fourier transform. Spectral acquisition and processing were both 
NMR Equipment and
Multivariate Statistical Analysis
A total of 92 spectra, 44 from cancer patients and 48 from control patients, were processed with a multivariate analysis. PCA, followed by PLS-DA, was performed with the AMIX 3.9.11 software package (Bruker BioSpin). Each 1D spectrum area in the range of 0.50 to 10.00 ppm was bucketed into a frequency window of 0.05 ppm (rectangular bucketing amplitude). The region corresponding to water (5.00-4.50 ppm) was excluded during binning to prevent artifacts due to the presaturation of water. All original spectral variables were preprocessed with meancentered and Pareto-scaling procedures before their analysis. With each principal component being a linear combination of the original variables (peak areas) and with each successive principal component i (PCi) explaining (progressively to a lower extent) the maximum amount of variance possible in the data set, PCA was used to determine whether the spectra could be clustered into separate groups, with each individual group made of similar spectra. On the basis of the PCA results, when group clustering was found to be present in the ensemble of spectra, PLS-DA was performed to assess the goodness of such a separation, with the control-cancer, transudate-exudate, or cancer Acancer B condition used as the classifier for the clustering. Figure 2 shows typical 1 H-NMR 1D CPMG spectra of PEs from a patient with a bPE ( Fig. 2A ) and a patient with an mPE (Fig. 2B) . As in the multivariate analysis, the PCA results are presented in a graphical mode; more specifically, the scores and loadings of the principal components of the variance have been plotted. Each point in the score plot represents an individual sample (ie, an individual NMR spectrum), and each point in the loading plot represents 1 spectral region. These 2 plots are evaluated as a correlate ensemble, and we look for similar trends: the points that in the loading plot move away from the center (coordinate 0,0) represent the spectral regions that more strongly influence patterns (ie, clustering) in the score plot and, consequently, the molecules that mostly influence patterns in the NMR spectra, which are responsible for the perturbation and modification of the metabolic profiles. The percentages of the variance explanation by the principal components (principal component 1 [PC1], principal component 2 [PC2], . . . PCi) quantify the robustness of the clustering in the score plot: the higher the percentage of the variance explained, the higher the reliability of the clustering. Figure 3A shows the score and loading plots of the multivariate analysis performed for bPEs and mPEs, with PC1 and PC2 explaining 66.34% of the total variance (35.81% and 30.53%, respectively). When for the control group only the transudates (transudate benign pleural effusions [t-bPEs]) were considered, their discrimination from the pooled neoplastic exudates (mPEs) was improved. In this case, PC1 and PC2 explained 76.38% of the variance (40.89% and 35.49%, respectively), and this highlighted the suitability of 1 H-NMR-based metabonomics for discriminating bPEs from mPEs. Even better differentiation between the 2 classes of PEs was obtained when we considered an exudate subset, namely, the exudates from patients affected by a specific cancer histotype. In particular, the score and loading plots resulting from PCA for transudates (t-bPE) and exudates (mPE) taken from carcinoma-affected patients showed a clear differentiation between the 2 cohorts, with PC1 and PC2 accounting in this case for 83.15% of the total variance (45.64% and 37.51%, respectively). A PLS-DA analysis of the same data set used for PCA was then used to confirm the separation found with PCA, and the separation was estimated with the value of the root mean square error of calibration (RMSEC): the lower the RMSEC, the better the separation. The results obtained from PLS-DA confirmed the clear separation between bPEs and mPEs: with the control-cancer condition used as the classifier for the separation (with 0 assigned to the control and 1 assigned to cancer), the score and loading plot from PLS-DA reinforced the separation obtained by PCA (Fig. 3B) with good values for the RMSEC (0.272 for all bPEs vs all mPEs, 0.189 for t-bPEs vs all mPEs, and 0.181 for t-bPEs vs carcinoma exudate mPEs). Similar results were obtained when PCA and PLS-DA were performed on spectra recorded with a 1D diffusion-edited sequence, and this suggests that both low-molecular-weight molecules (metabolites) and high-molecular-weight molecules (lipids and lipoproteins) contributed to the separation of the samples in the bPE and mPE groups. When only bPEs were considered and a multivariate analysis was used to determine whether a transudate (t-bPE) could be distinguished from an exudate (exudate benign pleural effusion [e-bPE]), PCA and PLS-DA with 1D CPMG spectra produced poor separation. In this case, PC1 and PC2 for t-bPEs and e-bPEs accounted for 42.86% and 27.29% of the variance, respectively. Conversely, when PCA and PLS-DA were performed on spectra acquired with the diffusion-edited sequence, which allowed better visualization of the lipid signals (Fig. 4) , clear clustering into separate groups was obtained with both PCA (with PC1 and PC2 explaining 91.8% of the total variance) and PLS-DA (RMSEC, 0.225). These results suggest that 1 H-NMR metabonomics can distinguish t-bPEs from e-bPEs and that unlike mPEs, high-molecular-weight molecules (lipids and lipoproteins) are more important than small molecules for classifying an effusion as a transudate or an exudate.
RESULTS
DISCUSSION
Histological examination remains the cornerstone of cancer diagnosis, but mediastinoscopy, biopsy, and surgical resection are invasive procedures and are often unsuitable for an early diagnosis. Thus, clinicians and researchers continue to seek less invasive and more cost-effective diagnostic tests with the same reliability as histology. In this scenario, effusion cytology remains the most requested diagnostic test, although the morphologic interpretation of effusion cytology may be extremely difficult, and this can lead to false-negative results because of the frequently overlapping features of benign and malignant proliferations. 3, 20, 21 The introduction of immunocytochemical reactions on cell blocks has increased the diagnostic performance; however, they are not always satisfactory because of the cell paucity of samples. Moreover, different biochemical analyses of effusions for the quantification of known markers of disease have been proposed to increase the reliability of PEs. Proteomic profiling and genomic profiling have been proved to be useful tools for cancer diagnosis in effusions; however, just as with cytology, these techniques require a significant tumor component in the sample to achieve a reliable diagnosis, and so far, only a few molecular tests have been validated and approved for clinical use. In this scenario, beyond the advantage of using a patient's biofluids, 1 H-NMR-based metabonomics could find a set of biomolecules of potential interest as new cancer biomarkers: our results highlight that the separation along PC1 is mainly due to a few regions of the spectrum (1.00-0.80, 1.40-1.20, 2.10-2.00, and 4.20-4.10 ppm). In particular, the major contribution to clustering into separate groups is due to the increase in an mPE of the signals produced by lipids, lactate, and some branched-chain amino acids (leucine, isoleucine and valine). On the contrary, alanine and some aromatic amino acids (tyrosine, histidine, and phenylalanine) are invariant for bPEs and mPEs. The separations along PC2 instead are due to metabolites whose signals appear in the sugars' region. In this respect, the glucose signal seems to slightly decrease for an mPE, but we prefer not to stress such information because of the known frequently misleading significance of the glucose signal.
14 Moreover, our choice of acquiring NMR spectra at 310 K led to obscuring of the a-anomeric glucose signal, and this further reduced the reliability of the overall glucose signal. The temperature of 310 K (higher than the temperatures usually chosen for blood derivatives, which range from 298 to 300 K) 17, 22 was used for better detection in the lipidic area of 1 H-NMR profiles 16, 23 and, combined with the choice of not perturbing Figure 4 . Typical proton nuclear magnetic resonance 1-dimensional spectrum of a malignant pleural effusion acquired with a diffusion-edited pulse sequence to better visualize the contribution of higher molecular weight molecules (eg, lipids and lipoproteins). HDL indicates high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.
the biofluids via deproteinization procedures, allowed us to obtain clearer evidence of the contribution of the lipid signals, which increased for mPEs. In particular, the signals at 0.86, 1.27, 2.04, and 3.21 ppm, assigned to lipid CH 3 , lipid (CH 2 ) n , lipid CH 2 CH5CH, and phospholipid choline head groups, respectively 19, 24, 25 (Fig. 4) , suggest that in an mPE, low-density lipoprotein and very low-density lipoprotein increase, whereas high-density lipoprotein is invariant. Such results were confirmed by the multivariate statistical analysis when the neoplastic exudates were compared with the noncancer exudates; that is, the transudates (which normally have a low lipid content) were not considered in the control group, and this increased the potential discriminant meaning of the biomolecules. This result seems to be supported by very recent publications that emphasize the importance of lipidomic investigations for cancer and degenerative diseases 26, 27 : increased levels of low-density lipoprotein and very low-density lipoprotein in patients' plasma have been related to the supply of cholesterol needed by fast-growing tumor cells for membrane buildup, 19, 24 and an increased level of lipoproteins in PEs has been reported as a marker for modified permeability of the pleura, which allows an effusion to be classified as an exudate. 28 1 H-NMR spectroscopy requires a unit with a research NMR system and dedicated personnel. The turnaround time of the test is approximately 20 minutes, and it preserves the material, allows repetitions, and has virtually no cost; however, the system and the human resources needed to interpret the results are very expensive, and the financial estimate is far beyond its actual clinical practicability outside a research center. Nevertheless, we believe that human biofluid components will be at the center of future investigations.
In conclusion, the results obtained from our study seem to indicate that 1 H-NMR metabonomics is a simple and reliable technique for distinguishing between transudates and exudates for bPEs and between bPEs and mPEs. Although such results are promising, we must point out some limitations of the current study. First, a multicenter study with a large number of samples would provide a robust validation cohort for our results; the heterogeneity of the cancer histotypes and benign conditions of the investigated cohorts did not allow us to define a statistical model of a metabolic profile specific for each cancer. Therefore, further studies with larger cohorts, together with an examination of mPEs available at different cancer stages, would allow 1 H-NMR metabonomics to be considered as a potential technique for an early and cost-effective diagnosis of cancer and allow a metabolomic classification of cancer, which is still lacking.
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